Funding for this research was provided by:
Kay Yow Cancer Fund/V Foundation
National Institutes of Health (5P30 CA068485, CA091408 5 U54, K08CA148887, 2R01 CA089450)
National Institute of Mental Health (1UL1 RR024975)
Vanderbilt-Ingram Cancer Center (P30 CA68485)
National Cancer Institute (2P30 CA06848)
Received: 22 September 2017
Accepted: 14 February 2018
First Online: 27 February 2018
Ethics approval and consent to participate
: Institutional Review Board approval for the human tissue studies was obtained at Vanderbilt University Medical Center (VUMC). No patient consent was required for study of deidentified patient tissue.
: Not applicable.
: Authors Marnett, Khabele, and Crispens disclose potential conflicts of interest.Dr. Khabele reports grants from Kay Yow Cancer Fund/V Foundation, during the conduct of the study; other from Astra Zeneca, personal fees from Vertex Pharmaceuticals, personal fees from Genentech, outside the submitted work.Dr. Marnett reports grants from National Institutes of Health, grants from Kay Yow Cancer Fund/ V Foundation, during the conduct of the study.Dr. Crispens reports other from Janssen Pharmaceuticals (clinical trial), other from Astra-Zeneca (clinical trial), personal fees from Helomics, outside the submitted work.Authors Beeghly-Fadiel, Wilson, Keene, El Ramahi, and Xu disclose no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.